
|Videos|March 25, 2017
What Treatment Options Are Being Studied for Patients with Type 2 Diabetes?
There are several new options coming down the pipeline for patients with type 2 diabetes.
Advertisement
In this clip, Dhiren Patel, PharmD, CDE, BC-ADM FCCP, who is a professor of pharmacy practice at Massachusetts College of Pharmacy and Health Sciences School of Pharmacy, discusses with Pharmacy Times the treatment pipeline and what's next for treating patients with diabetes.
Dr. Patel discussed managing diabetes with insulin/GLP-1 receptor agonist combinations during a special session held in conjunction with APhA2017.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
A Paradigm Shift in Lipid Management: Highlights from the NLA 2026 Scientific Sessions Opening Session
2
ATTR-CM Red Flags, Treatment Evidence, and the Pharmacist's Role in Care
3
FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant Treatment of High-Risk Clear Cell RCC
4
Staging the Heart: NLA and EAS Reveal a New Era of Precision Lipidology and Imaging
5


































































































































